Literature DB >> 1293048

High dose aerosol pentamidine for secondary Pneumocystis carinii pneumonia prophylaxis in AIDS patients.

L Flamholc1, S Haidl, E Westin, L Borgdalen, T Prellner.   

Abstract

In a prospective trial of aerosolized pentamidine as secondary prophylaxis for Pneumocystis carinii pneumonia (PCP) 18 patients received 400 mg once weekly for a mean period of 15.5 months. Pentamidine aerosol was administered with an MA2 jet nebulizer. No PCP relapses were observed and no serious side effects occurred.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1293048     DOI： 10.1007/bf01710670

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  14 in total

1.  Inhaled or intravenous pentamidine therapy for Pneumocystis carinii pneumonia in AIDS. A randomized trial.

Authors:  G W Soo Hoo; Z Mohsenifar; R D Meyer
Journal:  Ann Intern Med       Date:  1990-08-01       Impact factor: 25.391

2.  Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease.

Authors:  J Ruskin; M LaRiviere
Journal:  Lancet       Date:  1991-02-23       Impact factor: 79.321

3.  Prevention of Pneumocystis carinii pneumonia relapse by aerosolised pentamidine, 60 mg biweekly, using an Acorn System 22 nebuliser.

Authors:  B N Jensen; T L Nielsen; B Lerche; T H Jensen; V Backer; L Mathiesen; J O Nielsen; P Skinhøj
Journal:  Scand J Infect Dis       Date:  1990

4.  Pneumocystis carinii pneumonia in Stockholm, Sweden: treatment, outcome, one-year-follow-up and pyrimethamine prophylaxis.

Authors:  C Lidman; A Ortqvist; P Lundbergh; I Julander; S Bergdahl
Journal:  Scand J Infect Dis       Date:  1989

5.  Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in zidovudine-treated AIDS patients.

Authors:  P M Girard; R Landman; C Gaudebout; A Lepretre; P Lottin; C Michon; P De Truchis; S Matheron; F Camus; R Farinotti
Journal:  Lancet       Date:  1989-06-17       Impact factor: 79.321

6.  Survival trends for patients with AIDS.

Authors:  G F Lemp; S F Payne; D Neal; T Temelso; G W Rutherford
Journal:  JAMA       Date:  1990-01-19       Impact factor: 56.272

7.  Short course of aerosol pentamidine as treatment of Pneumocystis carinii pneumonia in AIDS.

Authors:  L Flamholc; S Haidl; E Westin; T Prellner
Journal:  Scand J Infect Dis       Date:  1991

8.  Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS.

Authors:  M A Fischl; G M Dickinson; L La Voie
Journal:  JAMA       Date:  1988-02-26       Impact factor: 56.272

9.  Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial.

Authors:  G S Leoung; D W Feigal; A B Montgomery; K Corkery; L Wardlaw; M Adams; D Busch; S Gordon; M A Jacobson; P A Volberding
Journal:  N Engl J Med       Date:  1990-09-20       Impact factor: 91.245

10.  Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus.

Authors: 
Journal:  MMWR Suppl       Date:  1989-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.